Alzheimer's disease clinical variants show distinct neuroinflammatory profiles with neuropathology
Our data suggests that different involvement of neuroinflammation may add to clinical heterogeneity in AD, which has implications for neuroinflammation-based biomarkers and future therapeutics.
Authors
- Martijn W. Heymans (ORCID: https://orcid.org/0000-0002-3889-0921)
- Irene Frigerio (ORCID: https://orcid.org/0000-0003-1780-2862)
- Annemieke J.M. Rozemüller (ORCID: https://orcid.org/0000-0003-2528-4428)
- Laura E. Jonkman (ORCID: https://orcid.org/0000-0003-1479-3649)
- Jeroen J.M. Hoozemans (ORCID: https://orcid.org/0000-0002-2888-8967)
- Femke H. Bouwman (ORCID: https://orcid.org/0000-0002-0527-2270)
- Melissa E. Murray (ORCID: https://orcid.org/0000-0001-7379-2545)
- Henne Holstege (ORCID: https://orcid.org/0000-0002-7688-3087)
- Sven J. van der Lee (ORCID: https://orcid.org/0000-0003-1606-8643)
- Baayla D.C. Boon (ORCID: https://orcid.org/0000-0002-4922-3286)
- Wilma D. J. van de Berg (ORCID: https://orcid.org/0000-0002-6175-5357)
- Tjado H. J. Morrema
- John G. J. M. Bol
- Danae de Gooijer
- Yvon Galis ‐ de Graaf
Institutions
- Netherlands Institute for Neuroscience (NL)
- Jacksonville College (US)
- Amsterdam Neuroscience (NL)
- Mayo Clinic in Florida (US)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Neuropathology and Applied Neurobiology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1111/nan.13009
- Citations
- 4
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- National Alcohol Beverage Control Association
- Amsterdam University Medical Centers
- ZonMw
- Alzheimer Nederland
- National Institute on Aging